WeightWatchers (WW International)
- 🦄Became a unicorn2015
- 📈Peak valuation$8 Billion ’18
- 💔Became a Unitard2024
- 💸Last valuationWiped out
How it happened
WeightWatchers, the weight-management brand behind points-based diet programs and group meetings, surged to renewed prominence after Oprah Winfrey invested in 2015, and its market value climbed above $8B by 2018. GLP-1 drugs like Ozempic and Wegovy then gutted its core business; revenue slid to about $811M in 2024 and the stock fell under $1, and in May 2025 WW International filed a prepackaged Chapter 11 to wipe out $1.15B in debt. Glassdoor reviews traced the unraveling before the filing: employees described years of near-continuous restructuring and a revolving door of senior leaders, layoffs two or three times a year, and, for frontline coaches, closing workshops, stagnant pay, and benefits like the 401(k) match stripped away.
Employee accounts paraphrase anonymous, unverified reviews posted publicly on Glassdoor ↗. See our methodology.
Source: CNN / Bloomberg / SEC (stock peaked above $100 in 2018, market cap ~$8B; revenue fell to ~$811M in 2024 amid Ozempic/Wegovy disruption; Chapter 11 May 6 2025 to cut $1.15B debt)
